ST九芝(000989.SZ)公告称，公司股票交易于2025年5月6日 停牌一天，于5月7日开市起 复牌。公司股票 自5月7日起撤销其他风险警示，证券简称由"ST九芝"变更为"九芝堂"，证券代码仍为"000989"。撤销其 他风险警示后，公司股票交易日的涨跌幅限制由5%变更为10%。 ...

证券代码：000989 证券简称：ST九芝 公告编号：2025-043 九芝堂股份有限公司 2024 年度分红派息实施公告 公告文件 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈 述或重大遗漏。 特别提示： 截至本公告日，九芝堂股份有限公司（以下简称"公司"）通过股票回购专 用证券账户持有股份 9,660,000 股, 公司回购专用证券账户上的股份不参与 2024 年度权益分派，本次实际可参与权益分派的总股本为 846,282,012 股，公司本次 实际现金分红的总金额=（公司总股本-公司回购专用证券账户上的股份）×分配 比 例 = 实 际 参 与 分 配 的 总 股 本 ×分 配 比 例 ， 即 253,884,603.60 元 = （855,942,012-9,660,000）股×0.30 元/股=846,282,012 股×0.30 元/股。 因公司回购股份不参与分红，本次权益分派实施后，根据股票市值不变原则， 实施权益分派前后公司总股本保持不变，现金分红总额分摊到每一股的比例将减 小，因此，本次权益分派实施后除权除息价格计算时，每 10 股现金红利应以 2.9661 ...

Core Viewpoint - The company reported a significant decline in revenue and net profit for the first quarter, while cash flow from operating activities showed substantial growth [3]. Financial Performance - The company's operating revenue decreased by 25.36% compared to the same period last year, primarily due to a decline in sales of certain products [3]. - The net profit attributable to shareholders decreased by 19.40%, which is mainly attributed to the drop in operating revenue [3]. - The net cash flow from operating activities increased by 118.41%, driven by improved collection of sales receivables and a reduction in cash paid for goods and services [3]. Shareholder Information - The company underwent a change in control, with major shareholder Li Zhenguo transferring 53,500,000 shares (6.25% of total shares) to Heilongjiang Cheneng Venture Capital Co., Ltd. at a price of 7.19 yuan per share, totaling 384,665,000 yuan [6]. - Following the transfer, Cheneng Venture Capital became the controlling shareholder, with the Heilongjiang Provincial Government becoming the actual controller of the company [6]. Share Buyback - The company approved a share buyback plan, allocating between 50 million and 100 million yuan to repurchase shares for employee stock ownership plans or equity incentives [7]. - As of March 17, 2025, the company had repurchased 9,660,000 shares, representing 1.13% of the total share capital, with a total expenditure of approximately 76.2 million yuan [7]. Other Important Matters - The company’s wholly-owned subsidiary transferred 70% of its stake in Beijing Yue Rutang Traditional Chinese Medicine Clinic to Beijing Tenghu Health Technology Co., Ltd., resulting in the clinic no longer being included in the consolidated financial statements [8].

公告资料 证券代码：000989 证券简称：ST九芝 公告编号：2025-042 九芝堂股份有限公司 2024年年度股东大会决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导 性陈述或者重大遗漏。 特别提示： 1、本次股东大会未出现否决议案的情形。 2、本次股东大会未涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 1、会议召开情况 （1）现场会议召开时间：2025 年 4 月 23 日（星期三）下午 14:30 （2）网络投票时间： 通过深圳证券交易所（以下简称"深交所"）交易系统进行网络投票的具体时 间为 2025 年 4 月 23 日上午 9:15—9:25，9:30—11:30，下午 13:00—15:00； 通过深交所互联网投票系统投票的具体时间为：2025 年 4 月 23 日上午 9:15 至下午 15:00 的任意时间。 （3）召开方式：本次股东大会采用现场表决与网络投票相结合的方式召开。 公告资料 出席本次会议的股东（含代理人）732 名，代表股份 427,185,845 股，占公 司有表决权股份总数的 50.4780%。 （有表决权股份总数为公 ...

1 湖南启元律师事务所 关于九芝堂股份有限公司 2024年年度股东大会的 法律意见书 致：九芝堂股份有限公司 湖南启元律师事务所（以下简称"本所"）接受九芝堂股份有限公司（以下简 称"公司"）的委托，指派本所律师出席了公司 2024 年年度股东大会（以下简称"本 次股东大会"），对本次股东大会的召集和召开程序、出席会议人员及召集人的 资格、表决程序和表决结果的合法有效性进行律师见证，并发表法律意见。 本所律师根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中 华人民共和国证券法》（以下简称"《证券法》"）等我国现行法律法规、规范性 文件以及《九芝堂股份有限公司章程》（以下简称"《公司章程》"）等有关规定 出具本法律意见书。 本所及本所律师声明如下： （一）本所律师根据本法律意见书出具日以前已经发生或者存在的事实，严 格履行了法定职责，遵循了勤勉尽责和诚实信用原则，进行了充分的核查验证， 保证本法律意见书所认定的事实真实、准确、完整，所发表的结论性意见合法、 准确，不存在虚假记载、误导性陈述或者重大遗漏，并承担相应法律责任。 （二）本所律师出具本法律意见书是基于公司已承诺所有提供给本所律师的 文件的正 ...

Financial Performance - The company's revenue for Q1 2025 was ¥805,671,753.35, a decrease of 25.36% compared to ¥1,079,482,203.93 in the same period last year[4] - Net profit attributable to shareholders was ¥116,548,482.40, down 19.40% from ¥144,601,666.94 year-on-year[4] - Basic and diluted earnings per share were both ¥0.1377, representing an 18.47% decrease from ¥0.1689 in the same period last year[4] - Net profit for the current period is ¥121,831,502.30, a decline of 15.6% from ¥144,417,064.21 in the previous period[18] - The total comprehensive income amounted to CNY 121,831,502.30, down from CNY 144,417,064.21, indicating a decrease of about 15.6%[19] Cash Flow - The net cash flow from operating activities increased by 118.41%, reaching ¥55,661,035.20, compared to a negative cash flow of ¥302,402,236.01 in the previous year[4] - Cash flow from operating activities generated a net cash inflow of CNY 55,661,035.20, a significant improvement from a net outflow of CNY -302,402,236.01 in the previous period[22] - Cash inflow from investment activities totaled CNY 1,068,156,676.21, compared to CNY 191,392,274.42 in the previous period, marking an increase of approximately 460.5%[22] - Cash outflow from investment activities was CNY 1,524,113,532.89, up from CNY 358,226,823.95, indicating an increase of about 325.5%[22] - The net cash flow from financing activities was CNY 16,159,945.02, down from CNY 93,274,675.81, representing a decrease of approximately 82.7%[22] - The total cash and cash equivalents decreased by CNY 384,135,876.46, compared to a decrease of CNY 375,962,109.73 in the previous period[22] - The company received CNY 3,591,939.56 in tax refunds related to operating activities[22] - The company reported a significant increase in cash received from sales of goods and services, totaling CNY 528,065,623.62, compared to CNY 351,832,836.97 in the previous period[21] Assets and Equity - Total assets at the end of the reporting period were ¥5,388,206,440.25, an increase of 3.39% from ¥5,211,440,858.19 at the end of the previous year[4] - The company's equity attributable to shareholders rose by 3.11% to ¥3,869,760,901.38 from ¥3,753,212,418.98[4] - The total equity attributable to shareholders increased to ¥3,869,760,901.38, up from ¥3,753,212,418.98, showing a growth of 3.1%[15] Expenses - The company reported a 37.16% reduction in selling expenses, totaling ¥26,168,800.00, due to decreased revenue and cost-saving measures[6] - Total operating costs decreased to ¥665,265,010.85, a reduction of 28.4% compared to ¥928,718,084.94 last year[18] - Research and development expenses decreased to ¥24,366,474.33, down 22.4% from ¥31,431,947.80 in the previous period[18] - The company reported a significant increase in other income to ¥3,494,127.83 from ¥13,688,212.38, reflecting a decrease of 74.5%[18] Shareholder Information - The total number of common shareholders at the end of the reporting period is 40,372[8] - The largest shareholder, Heilongjiang Cheneng Investment Co., Ltd., holds 205,730,587 shares, accounting for 24.04% of total shares[8] - Li Zhenguo, the second-largest shareholder, holds 161,898,371 shares, representing 18.91% of total shares, with 161,548,778 shares pledged[8] - The company plans to transfer 53,500,000 shares (6.25% of total shares) from Li Zhenguo to Heilongjiang Cheneng Investment Co., Ltd. at a price of 7.19 RMB per share, totaling 384,665,000 RMB[9] - The company has repurchased 9,660,000 shares, which is 1.13% of the total shares, with a total expenditure of 76,200,959.71 RMB[10] - The company has set a share repurchase plan with a budget between 50 million RMB and 100 million RMB[10] - The company’s control will change to Heilongjiang Cheneng Investment Co., Ltd. after the share transfer is completed[9] - The top ten shareholders do not have any associated relationships or act in concert with each other[8] Taxation - The company experienced a 161.52% increase in taxes payable, amounting to ¥6,223,490.00, primarily due to increased VAT and corporate income tax[6] Contract Liabilities - The company recorded a 40.86% increase in contract liabilities, reaching ¥7,482,470.00, due to an increase in advance payments received[6] Investments - The company reported a significant increase in investment income, which was ¥637,670.00, down 46.97% from ¥1,202,430.00 in the previous year, attributed to changes in accounting methods[7] - Long-term equity investments rose slightly to ¥232,671,242.32 from ¥228,782,281.05, indicating a growth of 1.7%[14]

九芝堂股份有限公司 关于申请撤销其他风险警示的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性陈 述或重大遗漏。 特别提示：关于九芝堂股份有限公司（以下简称"公司"）申请撤销对公 司股票交易实施其他风险警示事项尚需深圳证券交易所核准，存在不确定性， 敬请广大投资者注意投资风险。 公告文件 证券代码：000989 证券简称：ST九芝 公告编号：2025-040 公司申请撤销股票交易其他风险警示的事项尚需深圳证券交易所审核，能否 获得深圳证券交易所核准尚且存在不确定性。公司将根据进展情况及时履行信息 披露义务。公司指定信息披露媒体为《中国证券报》《证券时报》《证券日报》《上 海证券报》和巨潮资讯网，公司所有信息均以在上述指定媒体刊登的信息为准， 请广大投资者理性投资，注意风险。 九芝堂股份有限公司董事会 2025 年 4 月 22 日 九芝堂股份有限公司 1 2025 年 3 月 28 日，公司披露了容诚会计师事务所（特殊普通合伙）出具的 标准无保留意见的《2024 年度审计报告》（容诚审字[2025]100Z0502）、标准无 保留意见的《2024 年度内部控制审计报告》 ...

证券代码：000989 证券简称：ST 九芝 九芝堂股份有限公司投资者关系活动记录表 | 类 | 序 | 提问内容 | 回复内容 | | --- | --- | --- | --- | | 别 | 号 | | | | | | | 投资者你好，公司一方面传统经营板块积极推进营销模式改革， | | | | | 优化资源配置，学术引领、品牌赋能，开发等级医疗，下沉基层 | | | | | 市场，新零售驱动赋能，打好各终端渠道的组合牌，深耕存量， | | | | | 拓展增量，集中力量，做大做强核心品种。创新经营板块进一步 | | | | 尊敬的李振国董事长，您好！做为持有九芝堂 | 思考梳理现有产品运营策略、市场运营策略、风险控制策略，扩 | | | | 股票的投资者，很关心九芝堂未来的发展！ | 大自营业务占比，探索搭建公司自营业务体系，形成公司品牌核 | | | | 2024 年年报营收和净利润双降，营收下降 | 心主打品类，扩大公司品牌和产品市场知名度。 | | 经 | | 19.9%，净利润下降 23.3%，是不是九芝堂现 | 另一方面坚持创新引领，加强产学研合作，聚焦重点项目，加速 | | 营 | 1 | ...

Core Viewpoint - The company has completed the rectification of internal control deficiencies and is applying to the Shenzhen Stock Exchange to revoke other risk warnings on its stock trading, as it meets the necessary conditions for such an application [2][3][14]. Group 1: Internal Control and Risk Management - The company has strengthened risk compliance awareness and enhanced internal control management during the reporting period, ensuring effective operation of internal controls [1]. - The company has received standard unqualified opinions from the accounting firm regarding its 2024 annual audit and internal control audit reports, indicating that the issues previously identified have been resolved [2][3][14]. - The independent directors have confirmed that the company does not face any delisting risk warnings or other risk warnings, supporting the application to revoke the risk warnings [3][14]. Group 2: Annual Report and Performance - The company disclosed its 2024 annual report on March 28, 2025, and will hold an online performance briefing on April 10, 2025, to provide investors with a comprehensive understanding of its situation [6][7]. - Investors are invited to submit questions in advance for the performance briefing, indicating the company's commitment to transparency and engagement with its shareholders [8]. Group 3: Financial Management and Investment - The company has authorized the use of idle funds for entrusted financial management, aiming to improve the efficiency of its capital utilization and increase investment returns [21][22]. - The company plans to use up to 1 billion yuan in principal for entrusted financial management, which can be rolled over, ensuring a cautious approach to investment and risk control [24][25].